Pipeline Overview

Asset
Indication
Preclinical
Phase I
Phase IIa
Phase IIb
Phase III
Resomelagon (AP1189)
Rheumatoid Arthritis -
1st-line treatment
Rheumatoid Arthritis -
DMARD-IR
Nephrotic syndrome (iMN)
Virus- Induced Respiratory Insufficiency
TXP-11
Prevention of organ failures in complicated surgery
Small Molecules and Peptides
Autoimmune and inflammatory conditions
Completed
Ongoing
Resolve Part B (Approved in IND)